The life sciences industry is front and center right now because of the COVID-19 pandemic. Headlines fill our TV and computer screens with the latest news and information, and we are all are eagerly awaiting an announcement that a vaccine is ready for distribution or that a treatment will cure or greatly reduce the severity of the virus.
Indiana’s life sciences industry is in the thick of this work and has stepped up to do some extraordinary things over the past seven months – developing new products and treatments; pivoting their traditional manufacturing to make personal protective equipment; and caring for patients who have been affected by this global pandemic.
Our state’s role in the efforts to combat the virus will continue to be a critical component for the foreseeable future, and Hoosiers stand to benefit from these innovative and determined efforts.
BioCrossroads developed this year’s Indiana Life Sciences Summit topics to shine a spotlight on some of this work from companies like Anthem, Cook Medical, Eli Lilly and Company, Covance/LabCorp, and Roche Diagnostics as well as research and findings from our research universities: Indiana University School of Medicine, Purdue University and the University of Notre Dame.
Our 17th annual event is on Wednesday, Oct. 7, and will be virtual, featuring both pre-recorded and live sessions that will dive into the work that our Indiana companies are doing – how they have been directly impacted; how is it influencing their strategy; and how they’ve uniquely collaborated both with local Indiana partners as well as those around the world.
In addition, infectious disease expert Dr. Gail Cassel will address how the industry can learn from the pandemic; how this outbreak differs from others; and her thoughts on how the industry has responded.
Aside from all of the considerable and significant efforts surrounding COVID-19, Indiana’s industries continue to focus on discovery, research, ingenuity and technology. As a result of the Indiana Life Sciences Summit and several other virtual sessions focused on innovation, the week of Oct. 5 has been tagged Indiana Innovation Week. On-line events including the Venture Club’s Innovation Showcase, TechStars Sports – Demo Day, Indiana Next Level Fund Summit, and the IBJ Life Sciences Power Breakfast are all taking place between Oct. 6 and 9 to highlight our advanced industries and what’s being done to move them forward and continue to innovate.
In a year like no other, we have all adapted in order to keep our industries moving. Let’s take this week to celebrate our contributions to innovation. Learning from all of our efforts will enable us to be a stronger, more nimble, and more productive economy, whether we are developing a drug to treat COVID-19 or creating new technologies to build patient profiles in the cloud.
Patricia Martin is President and CEO of BioCrossroads.